William Connors, Cesilia Nishi, Inna Sekirov, Victoria Cook, J. Johnston
{"title":"加拿大新的6个月口服预超耐药结核病治疗:新的治疗方案带来了新的实施挑战","authors":"William Connors, Cesilia Nishi, Inna Sekirov, Victoria Cook, J. Johnston","doi":"10.14745/ccdr.v49i01a04f","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":33496,"journal":{"name":"Canada Communicable Disease Report","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Nouveau traitement oral de six mois contre la tuberculose pré-ultrarésistante aux médicaments au Canada : les nouvelles options de traitement présentent de nouveaux défis de mise en œuvre\",\"authors\":\"William Connors, Cesilia Nishi, Inna Sekirov, Victoria Cook, J. Johnston\",\"doi\":\"10.14745/ccdr.v49i01a04f\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":33496,\"journal\":{\"name\":\"Canada Communicable Disease Report\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Canada Communicable Disease Report\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14745/ccdr.v49i01a04f\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canada Communicable Disease Report","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14745/ccdr.v49i01a04f","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Nouveau traitement oral de six mois contre la tuberculose pré-ultrarésistante aux médicaments au Canada : les nouvelles options de traitement présentent de nouveaux défis de mise en œuvre